Back to Search
JAMES CATTO, MD
MD
Surgery Physician
NPI: 1407944556Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Words of wisdom. Re: Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.
PMID 19650218·Eur Urol·2009
8-other
Behavior of urothelial carcinoma with respect to anatomical location.
PMID 17437794·J Urol·2007
4-observational
The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care?
PMID 17021907·J Mol Med (Berl)·2006
8-other
Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
PMID 16697867·J Urol·2006
8-other
Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression.
PMID 16406976·J Urol·2006
8-other
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
PMID 15753461·J Clin Oncol·2005
8-other
Genetic instability and transitional cell carcinoma of the bladder.
PMID 14678361·BJU Int·2004
6-review
Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
PMID 12712438·Int J Cancer·2003
8-other
Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
PMID 14519642·Clin Cancer Res·2003
8-other
FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
PMID 18584939·Eur Urol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3535 W 13 MILE RD, STE 205
ROYAL OAK, MI 48073 - Phone
- (248) 551-8180
Quick Facts
- NPI
- 1407944556
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile